Journal Mobile Options
Table of Contents
Vol. 56, No. 1, 2007
Issue release date: November 2007
Neuropsychobiology 2007;56:40–46

Sleep Quality Perception in the Chronic Fatigue Syndrome: Correlations with Sleep Efficiency, Affective Symptoms and Intensity of Fatigue

Neu D. · Mairesse O. · Hoffmann G. · Dris A. · Lambrecht L.J. · Linkowski P. · Verbanck P. · Le Bon O.
aSleep Laboratory, University Hospital Brugmann, Université Libre de Bruxelles, bSleep Laboratory, University Hospital Erasme, Université Libre de Bruxelles, Brussels, and cDepartment of Internal Medicine, Biomed Flanders, Gent, Belgium; dSleep Unit, Department of Oto-Rhino-Llaryngology, Kirchberg Hospital, Luxembourg, Luxembourg

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background/Aims: One of the core symptoms of the chronic fatigue syndrome (CFS) is unrefreshing sleep and a subjective sensation of poor sleep quality. Whether this perception can be expressed, in a standardized questionnaire as the Pittsburgh Sleep Quality Index (PSQI), has to our knowledge never been documented in CFS. Furthermore, correlations of subjective fatigue, PSQI, affective symptoms and objective parameters such as sleep efficiency are poorly described in the literature. Methods: Using a cross-sectional paradigm, we studied subjective measures like PSQI, Fatigue Severity Scale scores and intensity of affective symptoms rated by the Hamilton Depression and Anxiety scales as well as objective sleep quality parameters measured by polysomnography of 28 ‘pure’ (no primary sleep and no psychiatric disorders) CFS patients compared to age- and gender-matched healthy controls. Results: The PSQI showed significantly poorer subjective sleep quality in CFS patients than in healthy controls. In contrast, objective sleep quality parameters, like the Sleep Efficiency Index (SEI) or the amount of slow-wave sleep did not differ significantly. Subjective sleep quality showed a correlation trend with severity of fatigue and was not correlated with the intensity of affective symptoms in CFS. Conclusion: Our findings indicate that a sleep quality misperception exists in CFS or that potential nocturnal neurophysiological disturbances involved in the nonrecovering sensation in CFS are not expressed by sleep variables such as the SEI or sleep stage distributions and proportions.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Maquet D, Demoulin C, Crielaard JM: Chronic fatigue syndrome: a systematic review. Ann Readapt Med Phys 2006;49:337–347, 418–427.
  2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbings JG, Komaroff A, the International Chronic Fatigue Syndrome Study Group: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953–959.
  3. Scott LV, Medbak S, Dinan TG: Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998;97:450–457.
  4. American Sleep Disorders Association: International Classification of Sleep Disorders, Revised. Rochester, American Sleep Disorders Association, 1997.
  5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association Press, 1994.
  6. Janet P: Obsessions and Psychasthenia. Paris, Alcan, 1903.
  7. World Health Organization: International Classification of Diseases, ed 10. Geneva, World Health Organization, 1990.
  8. Gomborone JE, Gorard DA, Dewsnap PA, Libby GW, Farthing MJ: Prevalence of irritable bowel syndrome in chronic fatigue. J R Coll Physicians Lond 1996;30:512–513.
  9. Wessely S, Nimnuan C, Sharpe M: Functional somatic syndromes: one or many? Lancet 1999;354:936–939.
  10. Whelton CH, Salit I, Moldofsky H: Sleep, Epstein-Barr, virus infection, musculoskeletal pain and depressive symptoms in chronic fatigue syndrome. J Rheumatol 1992;19:6:939–943.
  11. Morris R, Sharpe M, Sharpley AL, Cowen PJ, Hawton K, Morris J: Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ 1993;306:1161–1164.
  12. Sharpley A, Clements A, Hawton K, Sharpe M: Do patients with ‘pure’ chronic fatigue syndrome (neurasthenia) have abnormal sleep? Psychosom Med 1997;59:592–596.
  13. Fischler B, Le Bon O, Hoffmann G, Cluydts R, Kaufman L, De Meirleir K: Sleep anomalies in the chronic fatigue syndrome. Neuropsychobiology 1997;35:115–122.
  14. Stores G, Fry A, Crawford C: Sleep abnormalities demonstrated by home polysomnography in teenagers with chronic fatigue syndrome. J Psychosom Res 1998;45;1:85–91.
  15. Ball N, Buchwald D, Schmidt D, Goldberg G, Ashton S, Armitage R: Monozygotic twins discordant for chronic fatigue syndrome. Objective measures of sleep. J Psychosom Res 2004;56:207–212.
  16. Guilleminault C, Poyares D, Rosa A, Kirisoglu C, Almeida T, Lopes MC: Chronic fatigue, unrefreshing sleep and nocturnal polysomnography. Sleep Med 2006;7:513–520.
  17. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
  18. Heitkemper M, Jarrett M, Burr R, Cain KC, Landis C, Lentz M, Poppe A: Subjective and objective sleep indices in women with irritable bowel syndrome. Neurogastroenterol Motil 2005;17:523–530.
  19. Elsenbruch S, Harnish MJ, Orr WC: Subjective and objective sleep quality in irritable bowel syndrome. Am J Gastroenterol 1999;94:2447–2452.
  20. Rechtschaffen A, Kales A (eds): A Manual of Standardized Terminology Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, US Government Printing Office, 1968.
  21. American Sleep Disorders Association: EEG arousals: scoring rules and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:174–184.
  22. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121–1123.
  23. Olson LG, Ambrogetti A, Sutherland DC: A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics 2003;44:38–43.
  24. Agnew HW, Webb WB, Williams RL: The first-night effect: an EEG study of sleep. Psychophysiology 1966;2:263–266.
  25. Le Bon O, Minner P, Van Moorsel C, Hoffmann G, Gallego S, Lambrecht L, Pelc I, Linkowski P: First-night effect in the chronic fatigue syndrome. Psychiatry Res 2003;120:191–199.
  26. Watson NF, Kapur V, Arguelles LM, Goldberg J, Schmidt DF, Armitage R, Buchwald D: Comparison of subjective and objective measures of insomnia in monozygotic twins discordant for chronic fatigue syndrome. Sleep 2003;26:324–328.
  27. Coates TJ, Killen JD, Silverman S, George J, Marchini E, Hamilton S, Thoresen CE: Cognitive activity, sleep disturbance, and stage specific differences between recorded and reported sleep. Psychophysiology 1983;20:243–250.
  28. Carskadon MA, Dement WC, Mitler MM, Guilleminault C, Zarcone VP, Spiegel R: Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry 1976;133:1382–1388.
  29. Le Bon O, Neu D, Valente F, Linkowski P: Paradoxical NREMS distribution in ‘pure’ chronic fatigue patients: a comparison with sleep apnea-hypopnea patients and healthy control subjects. J Chronic Fatigue Syndr, in press.
  30. Caplan C: Chronic fatigue syndrome or just plain tired? CMAJ 1998;159:519–520.
  31. Powell R, Dolan R, Wessely S: Attributions and self-esteem in depression and chronic fatigue syndromes. J Psychosom Res 1990;34:665–673.
  32. Demitrack MA, Crofford LJ: Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann NY Acad Sci 1998;840:684–697.
  33. Hubain P, Le Bon O, Vandenhende F, Van Wijnendaele R, Linkowski P: Major depression in males: effects of age, severity and adaptation on sleep variables. Psychiatry Res 2006;145:169–177.
  34. Adrien J: Neurobiological bases for the relation between sleep and depression. Sleep Med Rev 2002;6:341–351.
  35. Jones D, Gershon S, Sitaram N, Keshavan M: Sleep and depression. Psychopathology 1987;20(suppl 1):20–31.
  36. Rechtschaffen A: Current perspectives on the function of sleep. Perspect Biol Med 1998;41:359–390.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50